The Board of Directors has appointed Christoph Heinzen as the new Chief Executive Officer at Nexilis AG. Christoph Heinzen has a strong track record in various positions in the pharmaceutical, BioTech and MedTech Industry with more than 20 years of experience, e.g.  as Chief Operations and Technology Officer at LifeWatch AG, a company dedicated to ECG monitoring services.
Christoph holds an Ph.D. in process engineering (ETHZ) and MBA (BWI NDS ETHZ).

With great sadness Nexilis AG has to inform that Martin Horst passed away on October 21, 2019. Martin Horst has been the Managing Director of NEXILIS AG since 2015 and has made a decisive mark on the company. We will always keep Martin in a very good memory. We extend our sincere condolences to the bereaved family and help them in these difficult times.